Scott Syndrome (SCTS)

Alias:

Prothrombin Consumption Deficiency

Bdplt7

Scts

Bleeding Abnormality Due to Deficiency of Platelet Binding of Factor X

Bleeding Abnormality Due to Deficiency of Platelet Biding of Factor X

Prothrombin Consumption Inhibitor, Familial

Familial Prothrombin Consumption Inhibitor

Prothrombin Consumption Inhibitor Familial

Prothrombin Conversion Defect, Familial

Familial Prothrombin Conversion Defect

Prothrombin Conversion Defect Familial

Bleeding Disorder, Platelet-Type, 7

Platelet-Type Bleeding Disorder 7

Bleeding Disorder Platelet-Type 7

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Scott Syndrome, also known as prothrombin consumption deficiency, is related to factor viii deficiency and hemorrhagic disease. An important gene associated with Scott Syndrome is ANO6 (Anoctamin 6), and among its related pathways/superpathways are Infectious disease and Transport of inorganic cations/anions and amino acids/oligopeptides. The drug Thrombin has been mentioned in the context of this disorder. Affiliated tissues include bone marrow and spinal cord, and related phenotypes are abnormal bleeding and factor x activation deficiency

Related ID：

MALACARDS：SCT005

OMIM：262890

MESH：C563120